Clinical Trial Detail

NCT ID NCT02998268
Title Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Pembrolizumab

Carboplatin + Paclitaxel

Age Groups: adult senior

No variant requirements are available.